• Sourcing Solutions
  • Services & Membership
  • Help & Community
Business Type: Manufacturer, Trading Company Verified
Location: Anhui, China (Mainland) Verified
Main Products: Paracetamol,Aspirin-DL-Lysine,Vitamin H,Lysine,Glutamic Acid
Total Employees: Above 1000 People
Total Annual Revenue: Above US$100 Million
Year Established: 2008 Verified
Top 3 Markets: Domestic Market 75.00% Africa 6.00% Southeast Asia 5.00%
Certifications: GMP,GMP,GMP,GMP,GMP
Product Certifications: COS
The mainstay subsidiary of the BBCA Group, we are located in Hefei City, capital of eastern China's ...
The mainstay subsidiary of the BBCA Group, we are located in Hefei City, capital of eastern China's Anhui Province. The largest pharmaceutical enterprise in Anhui, we have been deemed as a high technology enterprise by both the Ministry of Science and Technology and Chinese Academy of Sciences. Moreover, we have also received national GMP certification, and been commended as a holder of a 'Trusted Drug Brand' by the Chinese government in 2006. Listed on the Shenzhen Stock Exchange on September 4, 2000, after obtaining the approval of the China Securities Regulatory Commission, we now have more than 5,000 employees and total capital of around RMB2.0 billion.

Engaged in pharmaceutical R&D, production and sales, we have five pharmaceutical plants and 45GMP certified production lines. Manufacturing biological pharmaceuticals, chemical pharmaceuticals and traditional Chinese medicines, our main series include antipyretic analgesic drugs, antibiotics, anti-tumor drugs, traditional Chinese medicine preparations, cardiovascular drugs, amino acids, oxytocic drugs, gonadotropic drugs, anti-ulcer drugs and nervous system drugs. Producing 11 formulations, including small and large volume injections, powder injections, capsules, powders, tablets, granules, films, eye drops and patches, we have 395 individual products and many types of raw materials available.

Now having more than 40 varieties of drugs under research or in development, some of these models have already entered the domestic market. Holding independent intellectual property rights for both our pharmaceuticals and processing technologies, we guarantee that all products are of the highest quality.

Boasting sales offices in more than 30 provinces, municipalities and autonomous regions around China, we are also exporting some products to clients in Southeast Asia, Africa, and South America. Continually seeking new distributors, we look forward to receiving all your detailed inquiries in the near future.

Production Capacity View More >

Factory Information
Product Name Units Produced
(Previous Year)
Highest Ever
Annual Output
Unit Type
Paracetamol powder 6000 Ton/Tons
DC90 2000 Ton/Tons
Paracetamol Tablet 800000000 Pole/Poles
Large Volume Transfusion 400000000 Piece/Pieces
Small Volume Powder Injection 40000000 Box/Boxes

Trade Capacity View More >

Trade & Market
Main Markets Total Revenue(%)
Domestic Market 75.00%
Africa 6.00%
Southeast Asia 5.00%
South America 5.00%
Mid East 3.00%
Eastern Europe 2.00%
South Asia 1.00%
Western Europe 1.00%
Eastern Asia 1.00%
North America 1.00%
Export Percentage: 21% - 30%
Export Mode: Using an agent
Have Own Export License
No. of Employees in Trade Department: 21-50 People
Email to this supplier